These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 9253829
1. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens. Bousquet E, Morvan H, Aitken I, Morgan JH. Vet Rec; 1997 Jul 12; 141(2):37-40. PubMed ID: 9253829 [Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs. Raemdonck DL, Tanner AC, Tolling ST, Michener SL. Vet Rec; 1994 Jan 01; 134(1):5-7. PubMed ID: 8128570 [Abstract] [Full Text] [Related]
3. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida? Dorey L, Hobson S, Lees P. J Vet Pharmacol Ther; 2017 Oct 01; 40(5):517-529. PubMed ID: 28101885 [Abstract] [Full Text] [Related]
4. Efficacy of doxycycline in feed for the control of pneumonia caused by Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs. Bousquet E, Pommier P, Wessel-Robert S, Morvan H, Benoit-Valiergue H, Laval A. Vet Rec; 1998 Sep 05; 143(10):269-72. PubMed ID: 9787419 [Abstract] [Full Text] [Related]
5. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Stipkovits L, Miller D, Glavits R, Fodor L, Burch D. Can J Vet Res; 2001 Oct 05; 65(4):213-22. PubMed ID: 11768127 [Abstract] [Full Text] [Related]
6. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens. Dorey L, Lees P. BMC Vet Res; 2017 Jun 23; 13(1):192. PubMed ID: 28645327 [Abstract] [Full Text] [Related]
10. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Dorey L, Hobson S, Lees P. Res Vet Sci; 2017 Apr 23; 111():93-98. PubMed ID: 28113129 [Abstract] [Full Text] [Related]
11. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs. Blackall PJ, Asakawa T, Graydon RJ, White M, Adamson M, Wade LK, Lowe LB. Aust Vet J; 1995 Jan 23; 72(1):35-6. PubMed ID: 8787526 [No Abstract] [Full Text] [Related]
12. In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens. Pijpers A, Van Klingeren B, Schoevers EJ, Verheijden JH, Van Miert AS. J Vet Pharmacol Ther; 1989 Sep 23; 12(3):267-76. PubMed ID: 2810475 [Abstract] [Full Text] [Related]
13. PK and PK/PD of doxycycline in drinking water after therapeutic use in pigs. Prats C, El Korchi G, Giralt M, Cristòfol C, Peña J, Zorrilla I, Saborit J, Pérez B. J Vet Pharmacol Ther; 2005 Dec 23; 28(6):525-30. PubMed ID: 16343284 [Abstract] [Full Text] [Related]
14. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. Blondeau JM, Fitch SD. PLoS One; 2019 Dec 23; 14(1):e0210154. PubMed ID: 30629633 [Abstract] [Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Dorey L, Pelligand L, Cheng Z, Lees P. J Vet Pharmacol Ther; 2017 Oct 23; 40(5):505-516. PubMed ID: 28090673 [Abstract] [Full Text] [Related]
16. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media. Dorey L, Hobson S, Lees P. Res Vet Sci; 2017 Apr 23; 111():43-48. PubMed ID: 27940285 [Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study. de Jong A, Thomas V, Simjee S, Moyaert H, El Garch F, Maher K, Morrissey I, Butty P, Klein U, Marion H, Rigaut D, Vallé M. Vet Microbiol; 2014 Aug 06; 172(1-2):202-15. PubMed ID: 24837878 [Abstract] [Full Text] [Related]
18. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida. Eamens GJ, Gonsalves JR, Whittington AM, Turner B. Aust Vet J; 2012 Jun 06; 90(6):225-34. PubMed ID: 22632286 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs. Yoshimura H, Ishimaru M, Endoh YS, Kojima A. J Vet Med B Infect Dis Vet Public Health; 2001 Sep 06; 48(7):555-60. PubMed ID: 11666039 [Abstract] [Full Text] [Related]
20. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Hannan PC, O'Hanlon PJ, Rogers NH. Res Vet Sci; 1989 Mar 06; 46(2):202-11. PubMed ID: 2704885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]